Last update 22 Mar 2025

BBI-2000

Overview

Basic Info

Drug Type
Synthetic peptide
Synonyms
BBI 2000, BBI-2111
Target-
Action
inhibitors, modulators
Mechanism
Cell movement inhibitors, Immunomodulators
Therapeutic Areas
Immune System DiseasesSkin and Musculoskeletal DiseasesRespiratory Diseases
Active Indication-
Inactive Indication
Allergic asthmaDermatitis, Allergic ContactDermatitis, Contact
Originator Organization
Syngenta Crop Protection AG
Active Organization-
Inactive Organization
Fresh Tracks Therapeutics, Inc.Fresh Tracks Therapeutics, Inc.Syngenta Crop Protection AG
Drug Highest PhaseDiscontinuedPhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with BBI-2000
NCT03089775
/ CompletedPhase 1
A Randomized, Controlled Study to Evaluate the Effect of Topically Applied BBI-2000 (5%) on Allergic Responses in Subjects With Contact Hypersensitivity to Diphencyprone
100 Clinical Results associated with BBI-2000
Login to view more data
100 Translational Medicine associated with BBI-2000
Login to view more data
100 Patents (Medical) associated with BBI-2000
Login to view more data
100 Deals associated with BBI-2000
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Dermatitis, Allergic ContactPhase 2-
Syngenta Crop Protection AG
-
Dermatitis, ContactPhase 2-
Fresh Tracks Therapeutics, Inc.Fresh Tracks Therapeutics, Inc.
-
Allergic asthmaPhase 1
Canada
Fresh Tracks Therapeutics, Inc.Fresh Tracks Therapeutics, Inc.
14 Mar 2017
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
view full example data
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free